Business News • MarketWire • Investor Relations Digital Campaigning and Media Solutions Provider Investor Candy Reports Radient Pharmaceuticals' Campaign Activities Generating Results

Investor Relations Digital Campaigning and Media Solutions Provider Investor Candy Reports Radient Pharmaceuticals' Campaign Activities Generating Results

Investor Relations Digital Campaigning and Media Solutions Provider Investor Candy Reports Radient Pharmaceuticals' Campaign Activities Generating Results

TUSTIN, CA--(Marketwire - December 28, 2010) - Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based company specializing in the research, development, and international commercialization of In Vitro Diagnostic (IVD) cancer tests, including its FDA-approved Onko-Sure® IVD cancer test, announced today its investor relations partner released RPC's campaign results.

View More : http://www.marketwire.com/mw/release.do?id=1374006&sourceType=3

Releted News by marketwire

Putnam Announces Dividend Rates for Multi-Class Open-End Funds